tag:blogger.com,1999:blog-14703787.post725537799530802960..comments2007-12-05T08:54:16.522-05:00Sarahhttp://www.blogger.com/profile/05185078182316296961noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-14703787.post-25948278835886430522007-12-05T08:54:00.000-05:002007-12-05T08:54:00.000-05:00Fascinating observations. I agree with your evaluations.<BR/><BR/>Have you noticed funding disclaimers on studies that had positive results for mainstream (i.e. big pharma) treatments? The honey board sponsorship would sound the conflict of interest alarm in any competent journalist's mind. But the bigger problem, I think, is the gross underfunding of research into non-pharmacological (or non- NEW, and therefore patentable and highly profitable, pharmacological) treatments.<BR/><BR/>I suppose that adequate treatment of the funding system for research in the US would require stand-alone reportage; you couldn't do it in a couple of paragraphs in an article about an individual study. But the disclosure is definitely a step in the right direction.Rachelhttp://www.blogger.com/profile/09446536368127720437noreply@blogger.com